CAR T cell therapy, which involves genetically modifying a patient's own immune cells to fight cancer, is a technique that ...

Since its release in 2024, the open-source platform BindCraft, developed at EPFL, has already disrupted the world of protein design. Physical interactions between proteins influence anything from cell ...

A vision of the future of protein engineering The new approach allows the identification of near-optimal binder templates from the human proteome, facilitating the humanization of designed therapies, ...

For the field of drug development, hitting the right target with atomic precision to achieve therapeutic effect remains the core challenge. While traditional R&D pipelines are dependent on ...

Anthropic's Claude Science performed impressively in a protein design exercise, designing binders against 14 out of 15 targets and improving, in many cases, on the results of design competitions ...

WATERTOWN, Mass.--(BUSINESS WIRE)--Dyno Therapeutics, Inc., a genetic technologies company applying AI to empower patients everywhere with genetic agency, today announced the launch of Dyno Psi-Phi ...

BOSTON--(BUSINESS WIRE)--Manifold Bio, a platform therapeutics company pioneering direct-to-vivo drug discovery, today announced a joint study with NVIDIA to validate Proteina-Complexa, NVIDIA's ...

Physical interactions between proteins influence anything from cell signaling and growth to immune responses, so the ability to control these interactions is of great interest to biologists.

Anthropic says its Claude models designed working protein binders against 14 of 15 targets in a campaign that outside labs then physically built and tested, a result the company is framing as early ...